Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's ...

Merck is expanding its pipeline and portfolio of cardio-pulmonary disease treatments by acquiring Verona Pharma plc.

Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...

Wall Street was relatively quiet with major indexes ticking up modestly as the Trump administration seeks to win more ...

Merck to acquire Verona Pharma for $10 billion, adding COPD drug Ohtuvayre to strengthen respiratory portfolio.

Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...

Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S.

The Ohio Department of Development and the Area Agency on Aging District 7 (AAA7) are once again offering assistance to help Ohio’s families stay cool during the hot summer months.

Merck & Co. Inc. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio ...

U.S. stock futures edge higher as investors watch for more tariffs updates, and Nvidia is on the cusp of becoming the first ...

Cleveland Clinic Abu Dhabi has made history by performing the Gulf region’s first-ever robotic lung transplant, making it one ...

A recent national study revealed ongoing symptom burden and communication gaps in COPD care, and provided physicians with ...